Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Hot
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
Archives
Rechercher
Rechercher
Récent
Plus ancien
Effacer
@BioWorld
Total
1081
Source
BioWorld
Recherche
--
BioWorld
6 janv. 2026
Drugs to Watch 2026: 11 therapies that could transform patient care
BioWorld
6 janv. 2026
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
BioWorld
6 janv. 2026
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
BioWorld
6 janv. 2026
Insilico inks $888M drug discovery partnership with Servier
BioWorld
6 janv. 2026
Scinopharm wins US FDA approval of multiple sclerosis drug
BioWorld
6 janv. 2026
Financings for Jan. 6, 2026
BioWorld
6 janv. 2026
Appointments and advancements for Jan. 6, 2026
BioWorld
6 janv. 2026
Other news to note for Jan. 6, 2026
BioWorld
6 janv. 2026
Regulatory actions for Jan. 6, 2026
BioWorld
5 janv. 2026
Med-tech gainers and losers for Dec. 29, 2025-Jan. 2, 2026
BioWorld
5 janv. 2026
US vaccine schedule slashed to international standards
BioWorld
5 janv. 2026
Appointments and advancements for Jan. 5, 2026
BioWorld
5 janv. 2026
Financings for Jan. 5, 2026
BioWorld
5 janv. 2026
Other news to note for Jan. 5, 2026
BioWorld
5 janv. 2026
Regulatory actions for Jan. 5, 2026
BioWorld
5 janv. 2026
Biggest gainers and losers for Dec. 29, 2025-Jan. 2, 2026
BioWorld
5 janv. 2026
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
BioWorld
5 janv. 2026
New Nav1.8 blockers disclosed in Jumpcan Pharmaceutical patent
Précédent
44 / 61
Suivant